Operating Lease, Right-of-Use Asset of NORTHWEST BIOTHERAPEUTICS INC from 31 Dec 2018 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
NORTHWEST BIOTHERAPEUTICS INC quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2018 to 30 Sep 2025.
  • NORTHWEST BIOTHERAPEUTICS INC Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $4,265,000, a 5.5% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

NORTHWEST BIOTHERAPEUTICS INC Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $4,265,000 -$250,000 -5.5% 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 $4,419,000 +$422,000 +11% 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 $4,246,000 +$176,000 +4.3% 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 $4,187,000 +$4,000 +0.1% 31 Dec 2024 10-Q 14 Nov 2025 2025 Q3
Q3 2024 $4,515,000 +$501,000 +12% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 $3,997,000 -$234,000 -5.5% 30 Jun 2024 10-Q 09 Aug 2024 2024 Q2
Q1 2024 $4,070,000 -$139,000 -3.3% 31 Mar 2024 10-Q 10 May 2024 2024 Q1
Q4 2023 $4,183,000 -$6,000 -0.14% 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q3 2023 $4,014,000 +$63,000 +1.6% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 $4,231,000 -$104,000 -2.4% 30 Jun 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 $4,209,000 -$500,000 -11% 31 Mar 2023 10-Q 10 May 2023 2023 Q1
Q4 2022 $4,189,000 -$700,000 -14% 31 Dec 2022 10-K 05 Mar 2024 2023 FY
Q3 2022 $3,951,000 -$978,000 -20% 30 Sep 2022 10-Q 09 Nov 2022 2022 Q3
Q2 2022 $4,335,000 -$772,000 -15% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 $4,709,000 -$431,000 -8.4% 31 Mar 2022 10-Q 10 May 2022 2022 Q1
Q4 2021 $4,889,000 +$400,000 +8.9% 31 Dec 2021 10-K 28 Feb 2023 2022 FY
Q3 2021 $4,929,000 +$602,000 +14% 30 Sep 2021 10-Q 15 Nov 2021 2021 Q3
Q2 2021 $5,107,000 +$871,000 +21% 30 Jun 2021 10-Q 16 Aug 2021 2021 Q2
Q1 2021 $5,140,000 +$806,000 +19% 31 Mar 2021 10-Q 17 May 2021 2021 Q1
Q4 2020 $4,489,000 -$190,000 -4.1% 31 Dec 2020 10-K 01 Mar 2022 2021 FY
Q3 2020 $4,327,000 -$128,000 -2.9% 30 Sep 2020 10-Q 15 Jan 2021 2020 Q3
Q2 2020 $4,236,000 -$432,000 -9.3% 30 Jun 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 $4,334,000 -$530,000 -11% 31 Mar 2020 10-Q 24 Jun 2020 2020 Q1
Q4 2019 $4,679,000 +$4,679,000 31 Dec 2019 10-K 31 Mar 2021 2020 FY
Q3 2019 $4,455,000 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 $4,668,000 30 Jun 2019 10-Q 09 Aug 2019 2019 Q2
Q1 2019 $4,864,000 31 Mar 2019 10-Q 10 May 2019 2019 Q1
Q4 2018 $0 31 Dec 2018 10-K 16 Mar 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.